+
データを開く
-
基本情報
登録情報 | データベース: PDB / ID: 1ias | ||||||
---|---|---|---|---|---|---|---|
タイトル | CYTOPLASMIC DOMAIN OF UNPHOSPHORYLATED TYPE I TGF-BETA RECEPTOR CRYSTALLIZED WITHOUT FKBP12 | ||||||
![]() | TGF-BETA RECEPTOR TYPE I | ||||||
![]() | TRANSFERASE / kinase / TGF-beta receptor / GS region | ||||||
機能・相同性 | ![]() extracellular structure organization / epicardium morphogenesis / vascular endothelial cell proliferation / parathyroid gland development / transforming growth factor beta ligand-receptor complex / regulation of cardiac muscle cell proliferation / myofibroblast differentiation / positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation / TGFBR2 Kinase Domain Mutants in Cancer / transforming growth factor beta receptor activity ...extracellular structure organization / epicardium morphogenesis / vascular endothelial cell proliferation / parathyroid gland development / transforming growth factor beta ligand-receptor complex / regulation of cardiac muscle cell proliferation / myofibroblast differentiation / positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation / TGFBR2 Kinase Domain Mutants in Cancer / transforming growth factor beta receptor activity / trophoblast cell migration / angiogenesis involved in coronary vascular morphogenesis / SMAD2/3 Phosphorylation Motif Mutants in Cancer / TGFBR1 KD Mutants in Cancer / positive regulation of mesenchymal stem cell proliferation / ventricular compact myocardium morphogenesis / positive regulation of extracellular matrix assembly / TGFBR3 regulates TGF-beta signaling / positive regulation of tight junction disassembly / cardiac epithelial to mesenchymal transition / mesenchymal cell differentiation / transforming growth factor beta receptor activity, type I / positive regulation of vasculature development / neuron fate commitment / activin receptor complex / activin receptor activity, type I / regulation of epithelial to mesenchymal transition / type II transforming growth factor beta receptor binding / receptor protein serine/threonine kinase / transmembrane receptor protein serine/threonine kinase activity / pharyngeal system development / activin binding / TGFBR1 LBD Mutants in Cancer / germ cell migration / filopodium assembly / coronary artery morphogenesis / embryonic cranial skeleton morphogenesis / activin receptor signaling pathway / ventricular trabecula myocardium morphogenesis / response to cholesterol / I-SMAD binding / transforming growth factor beta binding / collagen fibril organization / negative regulation of chondrocyte differentiation / lens development in camera-type eye / endothelial cell activation / positive regulation of filopodium assembly / anterior/posterior pattern specification / artery morphogenesis / skeletal system morphogenesis / ventricular septum morphogenesis / SMAD binding / negative regulation of endothelial cell proliferation / TGF-beta receptor signaling activates SMADs / roof of mouth development / positive regulation of SMAD protein signal transduction / blastocyst development / epithelial to mesenchymal transition / regulation of protein ubiquitination / bicellular tight junction / endothelial cell migration / positive regulation of epithelial to mesenchymal transition / cellular response to transforming growth factor beta stimulus / positive regulation of stress fiber assembly / Downregulation of TGF-beta receptor signaling / positive regulation of endothelial cell proliferation / TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) / transforming growth factor beta receptor signaling pathway / negative regulation of cell migration / thymus development / positive regulation of apoptotic signaling pathway / skeletal system development / post-embryonic development / negative regulation of extrinsic apoptotic signaling pathway / cell motility / kidney development / wound healing / peptidyl-serine phosphorylation / cellular response to growth factor stimulus / male gonad development / UCH proteinases / nervous system development / regulation of gene expression / heart development / positive regulation of cell growth / in utero embryonic development / receptor complex / positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction / Ub-specific processing proteases / protein kinase activity / regulation of cell cycle / endosome / intracellular signal transduction / cilium / positive regulation of cell migration / membrane raft / protein serine/threonine kinase activity / positive regulation of cell population proliferation / ubiquitin protein ligase binding / apoptotic process 類似検索 - 分子機能 | ||||||
生物種 | ![]() | ||||||
手法 | ![]() ![]() ![]() | ||||||
![]() | Huse, M. / Muir, T.W. / Chen, Y.-G. / Kuriyan, J. / Massague, J. | ||||||
![]() | ![]() タイトル: The TGF beta receptor activation process: an inhibitor- to substrate-binding switch. 著者: Huse, M. / Muir, T.W. / Xu, L. / Chen, Y.G. / Kuriyan, J. / Massague, J. | ||||||
履歴 |
|
-
構造の表示
構造ビューア | 分子: ![]() ![]() |
---|
-
ダウンロードとリンク
-
ダウンロード
PDBx/mmCIF形式 | ![]() | 324.2 KB | 表示 | ![]() |
---|---|---|---|---|
PDB形式 | ![]() | 268 KB | 表示 | ![]() |
PDBx/mmJSON形式 | ![]() | ツリー表示 | ![]() | |
その他 | ![]() |
-検証レポート
文書・要旨 | ![]() | 490.6 KB | 表示 | ![]() |
---|---|---|---|---|
文書・詳細版 | ![]() | 559 KB | 表示 | |
XML形式データ | ![]() | 64 KB | 表示 | |
CIF形式データ | ![]() | 86 KB | 表示 | |
アーカイブディレクトリ | ![]() ![]() | HTTPS FTP |
-関連構造データ
-
リンク
-
集合体
登録構造単位 | ![]()
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 |
| ||||||||
単位格子 |
|
-
要素
#1: タンパク質 | 分子量: 38920.641 Da / 分子数: 5 / 断片: CYTOPLASMIC DOMAIN (RESIDUES 162-503) / 由来タイプ: 組換発現 / 由来: (組換発現) ![]() 発現宿主: ![]() ![]() 参照: UniProt: P36897, EC: 2.7.1.37 #2: 化合物 | ChemComp-SO4 / |
---|
-実験情報
-実験
実験 | 手法: ![]() |
---|
-
試料調製
結晶 | マシュー密度: 3.91 Å3/Da / 溶媒含有率: 68.54 % 解説: While TbR-I does crystallize in the absence of FKBP12, the crystals diffract poorly and are difficult to handle. To circumvent this problem, we sought high affinity, small molecule inhibitors ...解説: While TbR-I does crystallize in the absence of FKBP12, the crystals diffract poorly and are difficult to handle. To circumvent this problem, we sought high affinity, small molecule inhibitors that might stabilize TbR-I and thereby allow growth of better crystals. High affinity inhibitors of this class of kinases are not widely available in the public domain. We were provided with a quinazoline derivative that specifically inhibits TbR-I with an IC50 significantly less than 10mM (NPC-30345, proprietary to Scios, Inc., a company not affiliated with any of the authors). Addition of NPC-30345 allows the TbR-I crystals to grow larger and to diffract X-rays to moderate resolution using synchrotron sources. It is not possible to build a detailed molecular model for the inhibitor at the resolution of the analysis without knowledge of its precise chemical structure, which is proprietary to Scios, Inc. As such, we have not included a model for the inhibitor in the refinement. Electron density maps calculated using structure factors (deposited) and the model allow visualization of density for the inhibitor. | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
結晶化 | 温度: 277 K / 手法: 蒸気拡散法, ハンギングドロップ法 / pH: 5.8 詳細: 100 mM MES pH 5.8, 2.4 M ammonium sulfate, 10 % glycerol v/v, 150 mM NaCl, 1 mM NPC-30345, VAPOR DIFFUSION, HANGING DROP, temperature 277K | |||||||||||||||
結晶 | *PLUS 溶媒含有率: 70 % | |||||||||||||||
結晶化 | *PLUS 温度: 4 ℃ / 手法: 蒸気拡散法 / PH range low: 5.8 / PH range high: 5.7 | |||||||||||||||
溶液の組成 | *PLUS
|
-データ収集
回折 | 平均測定温度: 100 K |
---|---|
放射光源 | 由来: ![]() ![]() ![]() |
検出器 | タイプ: ADSC QUANTUM 4 / 検出器: CCD / 日付: 2001年1月27日 |
放射 | モノクロメーター: Si 111 CHANNEL / プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
放射波長 | 波長: 0.948 Å / 相対比: 1 |
反射 | 解像度: 2.9→50 Å / Num. all: 66462 / Num. obs: 59616 / % possible obs: 89.7 % / Observed criterion σ(F): 0 / Observed criterion σ(I): 0 / 冗長度: 4.3 % / Biso Wilson estimate: 57.4 Å2 / Rmerge(I) obs: 0.08 / Rsym value: 0.08 / Net I/σ(I): 22 |
反射 シェル | 解像度: 2.9→30 Å / 冗長度: 2.7 % / Rmerge(I) obs: 0.312 / Mean I/σ(I) obs: 3.5 / Num. unique all: 2677 / Rsym value: 0.312 / % possible all: 61 |
反射 | *PLUS 最低解像度: 50 Å / Rmerge(I) obs: 0.08 |
反射 シェル | *PLUS % possible obs: 61.1 % |
-
解析
ソフトウェア |
| |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 構造決定の手法: ![]() 開始モデル: TGF-beta receptor from TGF-beta receptor/FKBP12 structure 解像度: 2.9→30 Å / 交差検証法: FREE R-VALUE / σ(F): 0 / σ(I): 0 / 立体化学のターゲット値: Engh & Huber
| |||||||||||||||||||||||||
原子変位パラメータ | Biso mean: 68.8 Å2
| |||||||||||||||||||||||||
Refine analyze |
| |||||||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 2.9→30 Å
| |||||||||||||||||||||||||
拘束条件 |
| |||||||||||||||||||||||||
ソフトウェア | *PLUS 名称: CNS / 分類: refinement | |||||||||||||||||||||||||
精密化 | *PLUS 最高解像度: 2.9 Å / 最低解像度: 30 Å / σ(F): 0 / % reflection Rfree: 10 % | |||||||||||||||||||||||||
溶媒の処理 | *PLUS | |||||||||||||||||||||||||
原子変位パラメータ | *PLUS Biso mean: 68.8 Å2 | |||||||||||||||||||||||||
拘束条件 | *PLUS
|